Versteeg, L., Adhikari, R., Robinson, G., Lee, J., Wei, J., Islam, N., . . . Pollet, J. (2024). Immunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate. PLoS Pathogens, 20(12), 1. https://doi.org/10.1371/journal.ppat.1012764
Chicago Style (17th ed.) CitationVersteeg, Leroy, et al. "Immunopeptidomic MHC-I Profiling and Immunogenicity Testing Identifies Tcj2 as a New Chagas Disease MRNA Vaccine Candidate." PLoS Pathogens 20, no. 12 (2024): 1. https://doi.org/10.1371/journal.ppat.1012764.
MLA (9th ed.) CitationVersteeg, Leroy, et al. "Immunopeptidomic MHC-I Profiling and Immunogenicity Testing Identifies Tcj2 as a New Chagas Disease MRNA Vaccine Candidate." PLoS Pathogens, vol. 20, no. 12, 2024, p. 1, https://doi.org/10.1371/journal.ppat.1012764.